Amanote Research
Register
Sign In
In Vitro and in Vivo Activity of NY-198, a New Difluorinated Quinolone.
Antimicrobial Agents and Chemotherapy
- United States
doi 10.1128/aac.31.6.854
Full Text
Open PDF
Abstract
Available in
full text
Categories
Infectious Diseases
Pharmacology
Date
June 1, 1987
Authors
T Hirose
E Okezaki
H Kato
Y Ito
M Inoue
S Mitsuhashi
Publisher
American Society for Microbiology
Related search
Enterohepatic Circulation of NY-198, a New Difluorinated Quinolone, in Rats.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Activity of HSR-903, a New Quinolone.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Comparative in Vitro Activity of a New Quinolone, AM-1091.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro and in Vivo Antibacterial Activities of CS-940, a New 6-Fluoro-8-Difluoromethoxy Quinolone.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Activity of Sparfloxacin (AT-4140), a New Quinolone Agent, Against Invasive Isolates From Pediatric Patients.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Ceftezole, a New Cephalosporin C Derivative. I. In Vitro and in Vivo Antimicrobial Activity.
Journal of Antibiotics
Drug Discovery
Pharmacology
In Vitro and in Vivo Activity of a New Small-Molecule Inhibitor of HDAC6 in Mantle Cell Lymphoma
Haematologica
Hematology
The in Vitro and in Vivo Activity of Ciprofloxacin
Journal of the Islamic Medical Association of North America
P200 Development of New Antimalarial Drugs : In Vitro and in Vivo Antimalarial Activity of Endoperoxides
Medical Entomology and Zoology
